Eton Pharmaceuticals (NASDAQ:ETON) traded higher in the premarket on Thursday after the U.S. FDA approved its oral hydrocortisone solution Khindivi as a replacement therapy for children with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results